| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cce74ae91129e276612f5855529149a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac316c4307d2a84add2bae0328f607bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_beaa69dd9cc534fa853442eef87c3ab8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fc9ac5b1a1c0d3567c0ac2f4a62a671 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2201-06113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-3577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-65 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-65 |
| filingDate |
2013-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d72739cd9d936135a27571fc1a7d54a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0d2bf1b21c919a6dc5f1b4af3ea0c0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4623f75d4dd4937d604386e69b0add71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61f3e1e82086b47e640a8a308c08fd13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e2d5ae9cdd16e70fd58007791503843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b34733cd8b69ab33ad8993becfc63852 |
| publicationDate |
2014-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2882673-A1 |
| titleOfInvention |
Raman, infrared, or raman-infrared analysis of peripheral blood plasma protein structure and its relation to cognitive development in alzheimer's disease |
| abstract |
The present invention relates to a Raman spectroscopy method for determining protein structure associated with global cognitive deterioration in Alzheimer's disease from the Raman spectroscopic analysis of a human blood sample, preferably of a human blood plasma sample, comprising obtaining at least one spectral value of at least one of the Raman spectrum regions comprised between 16001700 cm-1, between 910980 cm-1, between 730760 cm-1 and/or between 390450 cm-1, and where said spectral value allows obtaining an indication of the presence or absence of protein structure associated with a condition of Alzheimer's disease. The present invention also relates to a method for the infrared spectroscopic analysis of a blood sample, by means of additionally obtaining at least one spectral value of at least one of the infrared spectrum regions comprised between 1600 and 1700 cm-1, and/or between 1000 and 1150 cm-1 and/or between 1140 and 1190 cm-1 Optionally, the Raman spectroscopy method further comprises the infrared spectroscopic analysis of the same blood sample. The invention also relates to a diagnostic method for diagnosing Alzheimer's disease comprising measuring a Raman spectrum and/or an infrared spectrum of a plasma sample. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020240908-A1 |
| priorityDate |
2012-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |